Patent details

EP3088397 Title: COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER

Basic Information

Publication number:
EP3088397
PCT Application Number:
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP161659123
PCT Publication Number:
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
COMPOUNDS THAT ABROGATE THE CELL CYCLE G2 CHECKPOINT FOR USE IN THE TREATMENT OF CANCER
French Title of Invention:
COMPOSÉS CAPABLES DE SUPPRIMER LE POINT DE CONTROLE G2 DU CYCLE CELLULAIRE UTILE POUR LEUR LE TRAITEMENT DE CANCER.
German Title of Invention:
VERBINDUNGEN, DIE DEN G2-CHECKPOINT DES ZELLZYKLUS STILLLEGEN UND DADURCH EINE ANTIKREBSWIRKUNG AUFWEISEN
SPC Number:

Dates

Filing date:
11/04/2008
Grant date:
10/04/2019
EP Publication Date:
02/11/2016
PCT Publication Date:
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
10/04/2019
EP B1 Publication Date:
10/04/2019
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
11/04/2019
Expiration date:
11/04/2028
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
03/04/2019
 
 

Name:
CanBas Co., Ltd.
Address:
2-2-1, Otemachi, Numazu Shizuoka 410-0801, Japan (JP)

Inventor

1

Name:
HASEGAWA, Yoko
Address:
Japan (JP)

2

Name:
KAWABE, Takumi
Address:
Japan (JP)

3

Name:
SATO, Takuji
Address:
Japan (JP)

4

Name:
ISHIGAKI, Machiyo
Address:
Japan (JP)

5

Name:
YAMAMOTO, Sayaka
Address:
Japan (JP)

Priority

Priority Number:
911258 P
Priority Date:
11/04/2007
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/427; A61P 35/00; C07D 417/12;

Publication

European Patent Bulletin

1

Issue number:
201915
Publication date:
10/04/2019
Description:
Grant (B1)

2

Issue number:
201920
Publication date:
15/05/2019
Description:
Application number/publication number of the divisional application (Art. 76) changed

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages